Approval · Notice of Compliance 16848 · 2015
ADENOSINE INJECTION: Notice of Compliance 16848
Issued April 27, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16848
- Date
- April 27, 2015
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiarrhythmic
- Canadian reference product
- ADENOCARD (Fujisawa Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADENOSINE INJECTION | 02267659 | Marketed |
Medicinal ingredients
- ADENOSINE 3 MG per ML